Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2021 | Highlights from BTOG 2021

Alastair Greystoke • 23 Apr 2021
BTOG 2021

Alastair Greystoke, MBChB, MSc, PhD, MRCP, Northern Institute for Cancer Research, Newcastle University, Newcastle, UK, shares his highlights from the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021, commenting on the impacts of the COVID-19 pandemic.

Disclosures

Alastair Greystoke, MBChB, MSc, PhD, MRCP, has received consultancy and speaker fees from AstraZeneca, Amgen, Boehringer-Ingelheim, Bristol-Myers Squibb, Janssen/ J and J, Foundation Medicine, MSD, Novartis, Pfizer, Lilly, Takeda and Roche; and has received research funding from AstraZeneca.

More from Alastair Greystoke

6:20
Solid tumor genomic testing in the UK: challenges and solutions
Alastair Greystoke • 28 Apr 2023
1:51
NHS England: a pilot ctDNA study to track patient responses to novel genomic targets
Alastair Greystoke • 27 Apr 2023
5:59
Deciphering an NGS report in lung cancer
Alastair Greystoke • 24 Jan 2022
3:34
Strategies to improve biomarker testing in the UK
Alastair Greystoke • 24 Jan 2022
The content of VJOncology is intended for healthcare professionals